Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.6900
+0.0700 (11.29%)
Oct 3, 2025, 3:58 PM EDT
Pharma-Bio Serv Market Cap
Pharma-Bio Serv has a market cap or net worth of $15.81 million as of October 3, 2025. Its market cap has decreased by -29.73% in one year.
Market Cap
15.81M
Enterprise Value
5.16M
Revenue
9.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.69
Market Cap Chart
Since December 4, 2006, Pharma-Bio Serv's market cap has decreased from 32.89M to 15.81M, a decrease of -51.92%. That is a compound annual growth rate of -3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 15.81M | 25.26% |
| Dec 30, 2024 | 12.62M | -47.64% |
| Dec 28, 2023 | 24.11M | 33.02% |
| Dec 30, 2022 | 18.13M | -23.58% |
| Dec 31, 2021 | 23.72M | -28.88% |
| Dec 31, 2020 | 33.35M | 66.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 684.21M |
| Glass House Brands | 634.90M |
| Northwest Biotherapeutics | 372.38M |
| CytoDyn | 330.58M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 287.31M |
| Silence Therapeutics | 245.62M |